Targeted drug delivery based on adhesion domains of immunoglobulin superfamily : P0 protein as a model
Date
1999-01-01
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
ORCID
Type
Degree Level
Doctoral
Abstract
The objectives of this study were (i) to investigate the feasibility of targeting liposomes reconstituted with P0 protein (an immunoglobulin [Ig] superfamily cell adhesion molecule from peripheral nerve myelin) to melanoma cells with high level of intercellular adhesion molecule-1 (ICAM-1) expression, (ii) to analyze selected sequences of P0 protein or leukocyte function associated antigen-1 (LFA-1, the counter receptor of ICAM-1) to find peptides with adhesive activity for ICAM-1 and (iii) to investigate whether these peptides could be used as ligands for targeting liposomes toward ICAM-1 expressing cells. To identify peptides with adhesive activity for ICAM-1 three synthetic P0 peptides (P0-peptide-1, YTDNGTF, extracellular Ig-like domain; P0-peptide-2, VALLVAV, transmembrane region; P0-peptide-3, KAAAEKK, basic intracellular domain) and one peptide from LFA-1 (a 12 amino acids long from 'I' domain) were selected. The effect of these peptides in the inhibition of LFA-1/ICAM-1 interaction might be through adhesion to ICAM-1. Peptides were covalently linked to the liposomes containing N-glutaryl-phosphatidylethanolamine in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysulfosuccinimide. P0-peptide-1, when linked to the liposome surface, increased the extent of binding of liposomes to M21 and A-375 compared to control liposomes of the same lipid composition but without peptide, whereas with MeM 50-10 (1.02 fold) cells no increase was found. Due to the high content of positively charged amino acids, P0-peptide-3 nonspecifically increased binding of liposomes to all the three melanoma cell lines. LFA-1- and RGD-peptides had no effect in the binding of liposomes to M21 cells. The extent of binding of P0-peptide-1-liposomes to human melanoma cell lines correlated with the level of ICAM-1 expression. P0 protein and P0-peptide-1 that mediate specific targeting of liposomes to ICAM-1 expressing cells may be useful for the development of drug delivery systems for the treatment of malignant melanomas and inflammatory skin disorders which have high level of ICAM-1 expression. (Abstract shortened by UMI.)
Description
Keywords
Citation
Degree
Doctor of Philosophy (Ph.D.)
Department
Pharmacy
Program
Pharmacy